Vanina Popova
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study.
Journal: Focus (American Psychiatric Publishing)
Published: August 01, 2026
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: July 02, 2025
Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study.
Journal: The international journal of neuropsychopharmacology
Published: December 11, 2024
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: December 31, 2023
A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics.
Journal: Neuropsychiatric disease and treatment
Published: April 13, 2023
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant.
Journal: Health and quality of life outcomes
Published: November 03, 2022
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: September 27, 2022
Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression.
Journal: Neuropsychiatric disease and treatment
Published: January 22, 2022
Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.
Journal: International journal of methods in psychiatric research
Published: October 05, 2021
Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials.
Journal: Neuropsychiatric disease and treatment
Published: September 14, 2021
Last Updated: 09/26/2026